Phenobarbitone (Sedabarb)

Phenobarbitone

Ranbaxy (SA) (Pty) Ltd

Registration

Applicant: Ranbaxy (SA) (Pty) Ltd
Certificate holder: Ranbaxy Pharmaceuticals (Pty) Ltd
Registrations: 1

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Sedabarb EACH TABLET CONTAINS PHENOBARBITONE 30 mg	30 mgTablet	E0107E/2.3/107Approved 10 November 2022	Registered	Not determined	PI PIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C₁₂H₁₂N₂O₃232.23 g/mol

5-Ethyl-5-phenyl-1,3-diazinane-2,4,6-trione

Drag to rotate. Structure from PubChem CID 4763.

SAHPRA documents

Professional information (PI)For healthcare professionals Patient information leaflet (PIL)For patients and carers

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading Wikipedia summary

Research articles

Loading PubMed articles